The chemical class known as Vmn2r2 Activators encompasses a diverse array of compounds that share the common characteristic of being able to influence the signaling mechanisms of the Vmn2r2 protein. Vmn2r2, a member of the vomeronasal type-2 receptor family, is involved in chemosensory processes, typically responding to pheromonal cues. The activators within this class do not bind directly to the receptor but instead engage in modulating the signaling pathways that affect Vmn2r2 activity. These activators operate by altering intracellular concentrations of second messengers such as cyclic adenosine monophosphate (cAMP) or by modulating the activity of specific kinases and phosphatases that are pivotal in the signaling cascades associated with Vmn2r2 function. The modulation of these pathways can lead to changes in Vmn2r2 activity, precisely by influencing the receptor's ability to transmit its signaling.
The activators that fall under the Vmn2r2 Activators class are particularly significant in the realm of cellular signaling because they can induce or enhance the receptor's signaling indirectly. They achieve this by either increasing the levels of intracellular messengers that are essential for the receptor's activity or by modifying the activity of enzymes that are critical for the signaling process, which in turn can promote the function of Vmn2r2. Such actions include the activation of adenylate cyclases or inhibition of phosphodiesterases, leading to elevated cAMP, or the modulation of protein kinases and calcium ion concentrations, which are all crucial elements in the signaling pathways that the Vmn2r2 receptor utilizes. By affecting these pathways, these activators exert influence over the physiological processes in which Vmn2r2 is implicated, despite not interacting with the receptor in a direct ligand-receptor binding manner.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylate cyclase, thereby increasing intracellular cAMP levels, which could possibly activate Vmn2r2 by modulating its signaling. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, which raises intracellular cAMP by preventing its degradation, and could possibly activate Vmn2r2 signaling pathways. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Rolipram selectively inhibits phosphodiesterase-4, increasing cAMP in cells, which could possibly activate Vmn2r2-mediated pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC), which could phosphorylate downstream proteins in GPCR pathways, possibly activating Vmn2r2 signaling. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 facilitates the influx of calcium ions, altering intracellular calcium levels, which could possibly activate Vmn2r2 by activating downstream calcium-sensitive pathways. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $442.00 | 3 | |
Pertussis toxin inhibits Gi proteins, potentially increasing cAMP levels and could possibly activate Vmn2r2 signaling. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $61.00 $122.00 | 1 | |
Nicotinic acid can engage GPCRs to modulate adenylate cyclase activity and cAMP levels, which could possibly activate Vmn2r2 function. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $33.00 $47.00 $294.00 $561.00 $1020.00 $2550.00 $4590.00 | 1 | |
Adenosine interacts with its GPCRs to adjust adenylate cyclase activity and cAMP levels, which could possibly activate Vmn2r2 pathways. | ||||||